Thiamylal sodium

Thiamylal sodium is an ultrashort-acting barbiturate used for inducing anesthesia in surgical procedures. It is also used for short-term sedation in critical care and for controlling seizures in emergency situations. It acts by depressing the central nervous system, leading to sedation or unconsciousness. It is grouped under the following drug class(es): Barbiturates. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Anestatal, Surital sodium and Surital. It is listed as a controlled drug substance (Schedule III). Its PubChem CID is 23677058.